Correction: Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells

Ítems similars

• Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells
  per: Zhu, Jinshun, et al.
  Publicat: (2020)
• Novel EBV LMP-2-affibody and affitoxin in molecular imaging and targeted therapy of nasopharyngeal carcinoma
  per: Zhu, Shanli, et al.
  Publicat: (2020)
• Novel EBV LMP-2-affibody and affitoxin in molecular imaging and targeted therapy of nasopharyngeal carcinoma.
  per: Shanli Zhu, et al.
  Publicat: (2020-01-01)
• Identification and characterization of novel B-cell epitopes within EBV latent membrane protein 2 (LMP2)
  per: Xue, Xiangyang, et al.
  Publicat: (2011)
• Generation of affibody molecules specific for HPV16 E7 recognition
  per: Xue, Xiangyang, et al.
  Publicat: (2016)